FDA issued public health advisory urging health professionals to limit the use of Cox-2 selective agents
In 2004, Merck announced a voluntary worldwide withdrawal of Vioxx (rofecoxib) because of an increased risk of heart…
In 2004, Merck announced a voluntary worldwide withdrawal of Vioxx (rofecoxib) because of an increased risk of heart…
In 2004, the Sarah Cannon Research Institute was formed to bring together community-based physicians, researchers and clinicians to…
In 2004, the U.S. Congress passed the Anabolic Steroid Control Act which enacted a ban on over-the-counter steroid…
On Jun. 21, 2004, the Huntsman Cancer Center Hospital was dedicated featuring a full-field digital mammography unit, a…
In 2004, the FDA published “Innovation or Stagnation? — Challenge and Opportunity on the Critical Path to New…
In 2004, William Hagopian, M.D., Ph.D., launched The Environmental Determinants of Diabetes in the Young (TEDDY) study at…
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…
In 2004, Wisconsin Governor Jim Doyle proposed the Wisconsin Institutes for Discovery (WID), a UW-Madison research enterprise, to…
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…
On Nov. 21, 2003, Cialis (tadalafil), discovered through a Glaxo Wellcome and ICOS Corp. partnership, was first approved…
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
On Nov. 12, 2003, Iowa State University announced new soybean varieties, that don’t need to be hydrogenated, that…
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…
On Oct. 15, 2003, the Immunization Practices Advisory Committee (ACIP) voted to recommend that children 6 to 23…
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
On Oct. 9, 2003, The Scripps Research Institute (TSRI) announced the establishment of a major science center in…
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
On Sept. 16, 2003, The Allen Institute for Brain Science, a division of the Allen Institute, was established…
On Sept. 4, 2003, the National Center for Research Resources (NCCR) awarded a $6.7 million grant to the…
On Sept. 3, 2003, the death rates from the four most common cancers, – lung, breast, prostate, and…
On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…
On Jul. 11, 2003, the U.S. Food and Drug Administration (FDA) published a final rule in the Federal…
On Jul. 10, 2003, the University Fertility Consultants at Oregon Health & Science University (OHSU) announced they had…
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…
On Jul. 2, 2003, Invitrogen bought Molecular Probes for $325 million in cash. The company became part of…
In Jul. 2003, HB 3613 was passed in the Oregon State Legislature and enacted a mandate for the…
In July 2003, University of Saskatchewan researchers announced they had discovered “follicular waves” in the human menstrual cycle….
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
On Jun. 20, 2003, NanoString Technologies was incorporated in Seattle as a spin-off from the Institute for Systems…